Current through Register Vol. XLI, No. 44, November 1, 2024
Section 11-10-2 - Definitions2.1. As used in this rule, the following words and terms have the following meaning: 2.1.a. "Administering" means the direct application of a drug to the body of a patient by injection, inhalation, ingestion or any other means.2.1.b. "Benzodiazepine" means a class of controlled substance medications that produce sedation, induce sleep, relieve anxiety and prevent seizures and which are generally approved to treat anxiety disorder, insomnia, seizures, social phobia, and panic disorder.2.1.c. "Board" means the West Virginia Board of Medicine as described at W. Va. Code § 30-3-5.2.1.d. "Controlled substance" means a drug that is classified by federal or state law in Schedules I, II, III, IV or V, as defined in W. Va. Code Chapter 60A, Article 2.2.1.e. "CSMP" means the West Virginia Controlled Substances Monitoring Program repository and database.2.1.f. "DEA registration identification number" means the federal Drug Enforcement Administration registration identification number issued to a practitioner.2.1.g. "Dispensing" means the preparation and delivery of a drug to an ultimate user by or pursuant to a lawful order of a practitioner, including the prescribing, packaging, labeling, administering or compounding necessary to prepare the drug for that delivery.2.1.h. "Medical records" means records including the medical history and physical examination; diagnostic, therapeutic and laboratory results; evaluations and consultations; treatment objectives; discussion of risks and benefits; informed consent; treatments; medications (including date, type, dosage and quantity provided); instructions and agreements; and periodic reviews.2.1.i. "Opioid" means controlled substance medications which are natural and semi-synthetic derivatives of the opium poppy, as well as similar synthetic compounds that have analgesic or pain relieving properties because of their effects in the central nervous system. Opioids include, but are not limited to, codeine, morphine, hydromorphone, hydrocodone, oxycodone, methadone, and fentanyl.2.1.j. "Patient" means a person presenting himself or herself for treatment who is not considered by the practitioner as suffering from a terminal illness.2.1.k. "Practitioner" means a physician, podiatric physician or physician assistant who possesses a valid DEA registration identification number and who is licensed by the Board pursuant to Articles 3 or 3E of Chapter 30, or holds an interstate telehealth registration issued by the Board pursuant to W. Va. Code § 30-1-26.2.1.l. "Providing" means prescribing, dispensing or administering medication.2.1.m. "Terminal illness" means an incurable or irreversible condition as diagnosed by the attending physician or a qualified physician for which the administration of life-prolonging intervention will serve only to prolong the dying process.